Published in Biochem J on December 15, 1983
Rates of protein turnover in vivo and in vitro in ventricular muscle of hearts from fed and starved rats. Biochem J (1984) 1.16
Regulation of protein turnover in skeletal and cardiac muscle. Biochem J (1991) 1.11
Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci U S A (1991) 1.02
Effects of pressure overload and insulin on protein turnover in the perfused rat heart. Prostaglandins are not involved although their synthesis is stimulated by insulin. Biochem J (1987) 0.95
The effects of 6 hours of hypoxia on protein synthesis in rat tissues in vivo and in vitro. Biochem J (1985) 0.94
Effects of increasing extracellular pH on protein synthesis and protein degradation in the perfused working rat heart. Biochem J (1989) 0.89
Regional variation and differential sensitivity of rat heart protein synthesis in vivo and in vitro. Biochem J (1985) 0.89
The effects of lactate, acetate, glucose, insulin, starvation and alloxan-diabetes on protein synthesis in perfused rat hearts. Biochem J (1986) 0.88
Correlations between cardiac protein synthesis rates, intracellular pH and the concentrations of creatine metabolites. Biochem J (1991) 0.81
A comparison of rates of protein turnover in rat diaphragm in vivo and in vitro. Biochem J (1986) 0.79
The effects of the exogenous provision of lactate and the endogenous production of lactate on protein synthesis in the heart. Biochem J (1992) 0.78
Regional glucose uptake and protein synthesis in isolated perfused rat hearts immediately after training and later. Basic Res Cardiol (1987) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Utilization of energy-providing substrates in the isolated working rat heart. Biochem J (1980) 2.94
Effect of insulin on protein turnover in heart muscle. J Biol Chem (1975) 1.53
Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J (1983) 1.36
Protein synthesis and amino acid transport in the isolated rabbit right ventricular papillary muscle. Effect of isometric tension development. Circ Res (1972) 1.30
An ultrasensitive isotope dilution method for the determination of L-amino acids. Anal Biochem (1970) 1.28
The effects of glucose, acetate, lactate and insulin on protein degradation in the perfused rat heart. Biochem J (1982) 1.26
Effects of noncarbohydrate substrates on protein synthesis in muscle. Am J Physiol (1974) 1.22
Effect of pressure development on membrane transport of glucose in isolated rat heart. Am J Physiol (1967) 1.20
The effects of insulin on glucose uptake and lactate release in perfused working rat heart preparations. Biochem J (1982) 1.18
Protein synthesis in the overloaded mammalian heart. Am J Physiol (1966) 1.16
Inhibition of protein degradation by anoxia and ischemia in perfused rat hearts. J Biol Chem (1979) 1.16
Biochemical and cellular changes in cardiac hypertrophy. Annu Rev Med (1972) 1.15
In vitro work load and rat heart metabolism. I. Effect on protein synthesis. Acta Physiol Scand (1972) 1.05
Protein synthesis and degradation in cardiac stress. Circ Res (1981) 1.02
The effect of pressure or flow stress on right ventricular protein synthesis in the face of constant and restricted coronary perfusion. J Clin Invest (1975) 1.02
Differential rates of protein synthesis in vitro and RNA contents in rat heart ventricular and atrial muscle. Biochem J (1983) 1.00
Muscle and non-muscle cell RNA polymerase activity during the development of myocardial hypertrophy. J Mol Cell Cardiol (1978) 0.98
Effect of insulin and lack of effect of workload and hypoxia on protein degradation in the perfused working rat heart. Biochem J (1983) 0.97
Effects of glucose, pyruvate, lactate, and amino acids on muscle protein synthesis. Am J Physiol (1982) 0.96
Molecular aspects of cardiac hypertrophy. Annu Rev Physiol (1979) 0.95
Regulation of protein synthesis and degradation during in vitro cardiac work. Am J Physiol (1980) 0.90
Changes in ribonucleic acid and protein synthesis during induced cardiac hypertrophy. Biochemistry (1971) 0.84
Studies on myocardial protein metabolism in cardiac hypertrophy. Jpn Heart J (1966) 0.81
In vitro work load and rat heart metabolism. II. Effect on amino acid transport. Acta Physiol Scand (1972) 0.78
In vitro work load and rat heart metabolism. 3. Effect on ribosomal aggregation. Acta Physiol Scand (1972) 0.78
Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med (1984) 15.06
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials (2001) 4.27
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20
Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect Immun (1974) 4.19
Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children. BMJ (1998) 4.14
Some characteristics of homosexual men. Br J Vener Dis (1976) 4.00
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91
Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52
Conformational change in the DNA associated with an unusual promoter mutation in a tRNA operon of Salmonella. Cell (1984) 3.44
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A (2003) 2.95
Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87
Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue. J Biol Chem (1977) 2.80
Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem (2001) 2.58
Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev (2000) 2.52
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1978) 2.32
Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann Occup Hyg (1987) 2.23
Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res (1999) 2.18
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol (1975) 2.05
Epithelial-mesenchymal signaling during the regionalization of the chick gut. Development (1998) 2.05
The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell (1998) 1.95
Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol (1998) 1.92
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Encouraging primary care physicians to help smokers quit. A randomized, controlled trial. Ann Intern Med (1989) 1.86
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology (2009) 1.83
Amino acid sequences around the sites of phosphorylation in the pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.78
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J (2006) 1.64
The loss of bone mineral with aging and its relationship to risk of fracture. J Clin Invest (1975) 1.61
Phosphorylation of additional sites on pyruvate dehydrogenase inhibits its re-activation by pyruvate dehydrogenase phosphate phosphatase. Biochem J (1978) 1.58
Purification and characterization of the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase from bovine liver. Biochem J (1976) 1.57
Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res (1996) 1.57
Regulation of kinase reactions in pig heart pyruvate dehydrogenase complex. Biochem J (1979) 1.54
The social work externship. J R Coll Gen Pract (1973) 1.53
Counseling medical and dental patients about cigarette smoking: the impact of nicotine gum and chart reminders. Am J Public Health (1987) 1.53
Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care (2001) 1.52
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem (1995) 1.50
Conversion of inactive (phosphorylated) pyruvate dehydrogenase complex into active complex by the phosphate reaction in heart mitochondria is inhibited by alloxan-diabetes or starvation in the rat. Biochem J (1978) 1.49
In vivo measurement of bone mass in the radius. Metabolism (1968) 1.46
Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem (1995) 1.45
The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab (1979) 1.45
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci U S A (1995) 1.45
Toward common ground. Diabetes Care (1997) 1.43
Servo control of end-tidal CO2 in paralyzed animals. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.42
Concurrent care: an ethical issue for family physicians. J Fam Pract (1993) 1.40
The enzymatic basis for the rat liver 6-hydroxymelatonin sulfotransferase activity. J Pineal Res (1995) 1.39
Widespread dissemination of Pneumocystis carinii infection in a patient with acquired immune deficiency syndrome receiving long-term treatment with aerosolized pentamidine. Am J Clin Pathol (1991) 1.39
Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care (2011) 1.38
Enzyme catalysis of 1,2-amino shifts: the cooperative action of B6, B12, and aminomutases. J Am Chem Soc (2001) 1.37
Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med (1998) 1.36
A case manager intervention to reduce readmissions. Arch Intern Med (1994) 1.36
Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol (1999) 1.31
An electromyographic diagnostic screening test in McArdle's disease and a case report. Neurology (1967) 1.30
Oxyntomodulin inhibits food intake in the rat. Endocrinology (2001) 1.29
The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett (1998) 1.28
The effects of glucose, acetate, lactate and insulin on protein degradation in the perfused rat heart. Biochem J (1982) 1.26
Regulation of pig heart pyruvate dehydrogenase by phosphorylation. Studies on the subunit and phosphorylation stoicheiometries. Biochem J (1978) 1.26
In vivo measurement of bone mass. Its use in demineralized states such as osteoporosis. JAMA (1972) 1.26
Nomenclature for factors of the SLA system, update 2008. Tissue Antigens (2009) 1.26
Activities of hexokinase, phosphofructokinase, 3-oxo acid coenzyme A-transferase and acetoacetyl-coenzyme A thiolase in nervous tissue from vertebrates and invertebrates. Biochem J (1973) 1.25
NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol (1998) 1.25
Regulation of pyruvate oxidation and the conservation of glucose. Biochem Soc Symp (1978) 1.25
Effect of citrate on the activities of 6-phosphofructokinase from nervous and muscle tissues from different animals and its relationships to the regulation of glycolysis. Biochem J (1977) 1.24
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes (2000) 1.22
Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett (1993) 1.22
Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem (1997) 1.21
Nonelective readmissions of medical patients. J Chronic Dis (1985) 1.21
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infect Immun (1996) 1.20
The effects of calcium ions, ionophore A23187 and inhibition of energy metabolism on protein degradation in the rat diaphragm and epitrochlearis muscles in vitro. Biochem J (1980) 1.19
Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol (1999) 1.18
Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res (2000) 1.18
The effects of insulin on glucose uptake and lactate release in perfused working rat heart preparations. Biochem J (1982) 1.18
Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol (1988) 1.18
Use of aromatic amino acids as monitors of protein turnover. Am J Physiol (1981) 1.17
Rates of protein turnover in vivo and in vitro in ventricular muscle of hearts from fed and starved rats. Biochem J (1984) 1.16
Age and activity effects on rate of bone mineral loss. J Clin Invest (1976) 1.16
Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J (1998) 1.15
Predictors of myocardial infarction in emergency room patients. Crit Care Med (1985) 1.15
Suppressor sufJ: a novel type of tRNA mutant that induces translational frameshifting. Proc Natl Acad Sci U S A (1984) 1.14
Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J Immunol (1991) 1.13
The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas. Am J Surg Pathol (1984) 1.12
The apparent inhibition of phosphofrunctokinase by reduced nicotinamide-adenine dinucleotide: a problem of coupled-enzyme assays. Biochem J (1970) 1.12
Alcohol related dementia: proposed clinical criteria. Int J Geriatr Psychiatry (1998) 1.12
Replication of the multidimensionality of activities of daily living. J Gerontol (1993) 1.12